Cannabicyclohexanol, formerly known as (±)-CP 47,497-C8-homolog, is a cannabinoid receptor agonist drug. It is a bicyclic cannabinoid (CB) analogue that avidly binds the CB1 receptor (Ki = 0.83 nM) and shows high antinociceptive activity. Cannabicyclohexanol is ten-fold more potent than Δ9-tetrahydrocannabinol in analgesic, motor depressant, anticonvulsant, and hypothermic effects in mice. Cannabicyclohexanol has four enantiomers, which by analoguey with other related cannabinoid compounds can be expected to have widely varying affinity for cannabinoid receptors, and consequently will show considerable variation in potency. Cannabicyclohexanol is not available (DEA controlled substance). References: Toyo'oka T, Kikura-Hanajiri R. A Reliable Method for the Separation and Detection of Synthetic Cannabinoids by Supercritical Fluid Chromatography with Mass Spectrometry, and Its Application to Plant Products. Chem Pharm Bull (Tokyo). 2015;63(10):762-9. doi: 10.1248/cpb.c15-00170. PubMed PMID: 26423032.

纯度：≥98%

CAS：70434-92-3